Latent infection and reactivation of Epstein-Barr virus
Daikoku, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 3): 584-588
2006
ISSN/ISBN: 0047-1852 PMID: 16615539 Document Number: 604964
Document emailed within 1 workday
Related Documents
Hopwood, P.A.; Brooks, L.; Parratt, R.; Hunt, B.J.; Bokhari, M.; Thomas, J.Alero.; Yacoub, M.; Crawford, D.H.; Maria, B.; Alero, T.J.; Magdi, Y. 2002: Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients Transplantation 74(2): 194-202Cacopardo, B.; Nunnari, G.; Mughini, M.T.; Tosto, S.; Benanti, F.; Nigro, L. 2003: Fatal hepatitis during Epstein-Barr virus reactivation European Review for Medical and Pharmacological Sciences 7(4): 107-109
Rek, O.; Cześcik, A.; Trzcińska, A.; Siennicka, J. 2010: Raji, P3HR-1 and Namalwa cells as a model for the study of Epstein-Barr virus (EBV) reactivation Medycyna Doswiadczalna i Mikrobiologia 62(3): 263-269
Skibiński, G.; James, K. 1989: Reactivation of antibody genes in Epstein-Barr virus transformed human B cell lines. A preliminary report Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 295-300
Satoh, M.; Oyama, N.; Akiba, H.; Ohtsuka, M.; Iwatsuki, K.; Kaneko, F. 2002: Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation European Journal of Dermatology: Ejd 12(4): 381-384
Larrat, S.; Morand, P.; Bas, A.; Vigne, S.; Crance, J.-M.; Boyer, V.ér.; Nicod, S.; Grossi, L.; Buisson, M.; Burmeister, W.P.; Seigneurin, J.-M.; Germi, R.ël. 2009: Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene Antiviral Therapy 14(5): 655-662
Quintanilla-Martínez, L.; Gamboa-Domńquez, A.; Gamez-Ledesma, I.; Angeles-Angeles, A.; Mohar, A. 1995: Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 8(6): 675-679
González, X.; Correnti, M.ía.; Rivera, H.; Perrone, M. 2010: Epstein Barr Virus detection and latent membrane protein 1 in oral hairy leukoplakia in HIV+ Venezuelan patients Medicina Oral Patologia Oral y Cirugia Bucal 15(2): E297-E302
Miller, C.L.; Lee, J.H.; Kieff, E.; Burkhardt, A.L.; Bolen, J.B.; Longnecker, R. 1994: Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction Infectious Agents and Disease 3(2-3): 128-136
Hamilton-Dutoit, S.J.; Pallesen, G. 1992: A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas American Journal of Pathology 140(6): 1315-1325
Du, C.; Wen, B.; Li, D.; Lin, Y.; Zheng, Y.; Peng, X.; Hong, C.; Chen, J.; Lin, W.; Hong, X.; Xie, L.; Wu, M. 2006: Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells Tumori 92(2): 140-148
Nurhantari, Y.; Emoto, N.; Rahayu, P.; Matsuo, M. 2003: Nasopharyngeal carcinoma in Indonesia has a low prevalence of the 30-base pair deletion of Epstein-Barr virus latent membrane protein 1 Southeast Asian Journal of Tropical Medicine and Public Health 34(1): 98-105
Smir, B.N.; Hauke, R.J.; Bierman, P.J.; Gross, T.G.; d'Amore, F.; Anderson, J.R.; Greiner, T.C. 1996: Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders Laboratory Investigation; a Journal of Technical Methods and Pathology 75(4): 575-588
Pinkus, G.S.; Lones, M.; Shintaku, I.P.; Said, J.W. 1994: Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 7(4): 454-461
Crawford, D.H.; Thomas, J.A.; Gregory, C.D.; Catovsky, D.; Chaggar, K. 1995: Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40 Leukemia 9(5): 747-753
Yang, T.-t.; Wang, Y.; Liu, X.; Li, X.; Pang, Z.-c.; Luo, B. 2009: Genotyping of Epstein-Barr virus in Epstein-Barr virus associated gastric carcinoma Bing du Xue Bao 25(1): 29-34
Kordek, R.; Biernat, W.; Kupnicka, D.; Woźniak, L. 1994: Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 45(4): 279-281
Ross, C.W.; Schnitzer, B.; Weston, B.W.; Hanson, C.A. 1991: Chronic active Epstein-Barr virus infection and virus-associated hemophagocytic syndrome Archives of Pathology and Laboratory Medicine 115(5): 470-474
Gutiérrez, J.; Rodríguez-Iglesias, M. 2000: Hepatitis C virus and Epstein-Barr virus: dual infection or atypical antibody response Microbios 103(404): 65-66
Hofmann, M.; Engels, M.; Metzler, A.E.; Wyler, R. 1986: Reactivation of a latent bovine herpes mamillitis virus (BHV-2) infection in an animal with questionable IBR serology Schweizer Archiv für Tierheilkunde 128(6): 289-297